Terazosin Capsule
Product Images NDC 70518-0342

5 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 70518-0342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fig 1)

Structure (Fig 1)
Chemical structure of Terazosin Hydrochloride depicted as a molecular diagram, showing its component rings, functional groups, and hydrochloride association.*
FDA Label Image

Figure2 (Fig 2)

Figure2 (Fig 2)
This image contains two line graphs comparing Placebo and Terazosin effects over 3 months. The left graph shows mean change in total symptom score from baseline with decreasing scores, favoring Terazosin. The right graph shows mean increase in peak flow rate (mL/sec) from baseline, with Terazosin showing greater improvement than Placebo. Sample sizes (N) are indicated for each group.*
FDA Label Image

Figure3 (Fig 3)

Figure3 (Fig 3)
A line graph showing the mean change from baseline over time in months, with data points from 0 to 30 months. The graph includes two lines with symbols, indicating measurement values at various time points, with the y-axis values ranging from 0 to -7.*
FDA Label Image

Figure4 (Fig 4)

Figure4 (Fig 4)
A line graph depicting the mean change from baseline to Day 1-30 in a variable measured in microliters per second (mL/sec). The x-axis represents time in months, while the y-axis shows mean change values ranging from 0 to 4.5. Data points include error bars, with multiple points marked by asterisks indicating statistical significance.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Terazosin 1 mg capsules, quantity 30, from RemedyRepack Inc. The label shows NDC 70518-0342-00 and manufacturer Cadista Pharma, Inc. It includes instructions to see package insert for directions for use, storage conditions (20-25°C), and a caution to keep medication out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.